- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
UPFSDA Busts Fake Mankind Pharma Drug Racket, Uncovers Illegal Manufacturing Units in Himachal

Lucknow: An investigation into the circulation of counterfeit medicines in Uttar Pradesh has exposed an alleged interstate pharmaceutical manufacturing and distribution network, leading authorities to two unauthorised drug manufacturing facilities in Himachal Pradesh.
According to a recent media report in India Today, joint teams of the Uttar Pradesh Food Safety and Drug Administration (UPFSDA) and the Special Task Force (STF) traced the suspected supply chain to manufacturing locations in Solan and Baddi. During the raids, officials recovered drug manufacturing machinery, raw materials, packaging equipment and medicines allegedly carrying the names of established pharmaceutical brands.
The investigation began after suspected counterfeit medicines were detected at a medical store in Varanasi. Subsequent inquiries helped investigators identify suppliers, storage locations and suspected manufacturing facilities operating outside Uttar Pradesh.
The latest action led to the discovery of an unlicensed manufacturing facility at V.D. Pharma in the Jhundikalan area of Baddi, following an earlier raid in Solan district. Himachal Pradesh drug control authorities and police have initiated further action in connection with the findings.
Varanasi raid leads to discovery of counterfeit medicines
The investigation started on October 30, 2026, when UPFSDA officials inspected SP Medical Store in Varanasi. The establishment was allegedly operating without a valid drug licence and was found selling Nurokind-LC tablets carrying the name of Mankind Pharma.
During questioning, the store owner reportedly informed investigators that the medicines had been purchased without invoices from a salesman associated with Super Drug Agency in Lahartara.
Following verification with Mankind Pharma and a comparative examination of the products, the medicines were identified as counterfeit. Officials also recovered other illegally stocked medicines estimated to be worth approximately Rs 5 lakh.
Bulk storage facility uncovered in Varanasi
Investigators subsequently questioned the alleged supplier and a delivery agent on November 2. Their statements led the team to a premises belonging to Surendra Nath Mishra in Varanasi.
Officials reportedly discovered 17 varieties of allopathic medicines stored without the required invoices or licences. Suspected irregularities, including spelling and labelling errors, were noticed on strips of Gudcef-Plus and Nurokind-LC.
Eleven medicine samples were collected for laboratory examination, while the remaining stock, valued at approximately Rs 2 lakh, was seized.
Investigation identifies alleged interstate supplier
During further questioning, Mishra reportedly named Abhishek Singh alias Ravi, a resident of Anpara in Sonbhadra district, as his alleged supplier. Investigators also found that the two communicated through the Zangi encrypted messaging application.
An FIR was subsequently registered at Rohania police station against four accused under relevant provisions of the Bharatiya Nyaya Sanhita (BNS).
The investigation also revealed that Abhishek Singh had previously been named as the main accused in a counterfeit medicine case registered at Varanasi's Sigra police station in 2023. His questioning reportedly provided investigators with leads about the locations where the suspected medicines were being manufactured.
Illegal manufacturing facility identified in Solan
Based on the information gathered during the investigation, a UPFSDA special investigation team, along with the Lucknow STF, conducted a raid on November 18 at a suspected manufacturing premises near the Rajpura-Khera bypass in Nalagarh tehsil of Solan district.
The facility was allegedly operating without a valid manufacturing licence. Officials recovered machinery, raw materials and packaging equipment suspected to have been used for producing counterfeit medicines and replicating the packaging of established pharmaceutical brands.
Several medicines, including Pan-D, Clavam-625, Shelcal-500 and Zerodol-SP, were among the products identified during the operation. Other names included Cef-200LB, A-Cipex-625, Neuro-300 and various antibiotic formulations.
The premises also contained blister-packing machines, Alu-Alu packaging equipment, capsule-filling machinery, weighing machines and printed pharmaceutical foils.
Second unauthorised unit found in Baddi
Further investigation led officials to another suspected pharmaceutical manufacturing facility operating under the name V.D. Pharma in Jhundikalan, Baddi.
According to the report, investigators found machinery and equipment used for manufacturing tablets, capsules and syrups. Raw materials, finished medicines and semi-finished products were also recovered.
The seized materials reportedly included products and ingredients associated with antibiotics, antacids and cough syrups.
Himachal Pradesh drug control authorities are examining the findings and taking further legal action against those allegedly involved.
Probe expands to Saharanpur
The investigation has also extended to locations in Saharanpur linked to two brothers, Haseen and Waseem, who were allegedly involved in arranging the manufacture and distribution of counterfeit medicines.
Investigators reportedly identified premises associated with the suspected illegal manufacture, storage and sale of pharmaceutical products. Further legal proceedings, including the registration of FIRs, are being initiated.
The investigation, which initially focused on suspected counterfeit medicines found at a Varanasi medical store, has now expanded to suppliers, storage facilities and manufacturing locations across multiple states, reports India Today.
Authorities are continuing their probe to establish the complete supply chain, identify all individuals and businesses involved, and determine how medicines bearing the names of established pharmaceutical companies entered the market.
M. Pharm (Pharmaceutics)
Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

